(Reuters) -Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a case that accused the London-listed firm and Abbott of failing to warn of the risks of premature-infant formulas.
The Thursday’s ruling comes after a St. Louis, Missouri state court last October found Reckitt unit Mead Johnson and Abbott not responsible for a young boy’s debilitating intestinal disease.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Anil D’Silva)
